Interview
Interviews are typically with authors on their recently published AJKD articles.
Kidney transplant recipients are at least twice as likely to develop cancer compared with immunocompetent people. Cancer is now the second leading cause of death in kidney
[...]
For many years, the only specific pharmacologic intervention to decrease end-stage kidney disease in diabetic kidney disease was renin-angiotensin-aldosterone system
[...]
Between 2006 and 2016, the number of US dialysis facilities experienced steady annual growth. Recent data suggest a reversal in this trend. Varkila et al examined trends in
[...]
In IgA nephropathy (IgAN), elevated levels of the circulating autoantigen galactose-deficient IgA1 are critical to disease pathogenesis. Genetic as well as in vitro, in vivo,
[...]
Rituximab effectively limits the number of relapses in childhood idiopathic nephrotic syndromes (INS) and reduces exposure to corticosteroids and other immunosuppressants.
[...]
Atrial fibrillation is common among patients with kidney failure treated with hemodialysis. A recent study published in AJKD by Winkelmayer et al examined the efficacy and
[...]
IgA nephropathy (IgAN) is the most common immune-mediated glomerular disease worldwide. Advanced understanding of the role of complement in IgAN pathogenesis has motivated
[...]
Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease, with lupus nephritis (LN) affecting up to 60% of patients. Early diagnosis and treatment are
[...]
Hyperphosphatemia remains a major challenge in managing patients with kidney failure and is associated with significant morbidity and mortality. In a Mini-Review recently
[...]
Chronic systemic inflammation, triggered by innate immune system activation, is a key driver of both chronic kidney disease (CKD) and associated atherosclerosis and
[...]